Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Schizophrenia

Free Subscription 18.03.2019 1 Am J Med Genet B Neuropsychiatr Genet 2 Biol Psychiatry 1 Br J Psychiatry 4 Compr Psychiatry 1 J Abnorm Psychol 1 J Nerv Ment Dis 2 Mol Psychiatry 1 Neuropsychology 1 PLoS One 9 Psychiatry Res 5 Psychol Med 14 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Med Genet B Neuropsychiatr Genet

1. AL EISSA MM, Sharp SI, O'Brien NL, Fiorentino A, et al
   Genetic association and functional characterization of MCPH1 gene variation in bipolar disorder and schizophrenia.
   Am J Med Genet B Neuropsychiatr Genet. 2019 Mar 11. doi: 10.1002/ajmg.b.32722.
   PubMed     Text format     Abstract available
   
   

   
   Biol Psychiatry

2. CHOUINARD VA
   Glutamatergic System and Neuroimaging Studies of Treatment-Resistant Schizophrenia.
   Biol Psychiatry. 2019;85:e31-e32.
   PubMed     Text format    
   
   
3. MORENO-DE-LUCA D, Ross ME, Ross DA
   Leveraging the Power of Genetics to Bring Precision Medicine to Psychiatry: Too Little of a Good Thing?
   Biol Psychiatry. 2018;83:e45-e46.
   PubMed     Text format    
   
   

   
   Br J Psychiatry

4. FORNARO M, Solmi M, Stubbs B, Veronese N, et al
   Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis.
   Br J Psychiatry. 2019 Mar 13:1-10. doi: 10.1192/bjp.2019.
   PubMed     Text format     Abstract available
   
   

   
   Compr Psychiatry

5. LASKEMOEN JF, Simonsen C, Buchmann C, Barrett EA, et al
   Sleep disturbances in schizophrenia spectrum and bipolar disorders - a transdiagnostic perspective.
   Compr Psychiatry. 2019;91:6-12.
   PubMed     Text format     Abstract available
   
   
6. STANGA V, Turrina C, Valsecchi P, Sacchetti E, et al
   Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study.
   Compr Psychiatry. 2019;91:1-5.
   PubMed     Text format     Abstract available
   
   
7. TONNA M, Paglia F, Ottoni R, Ossola P, et al
   Delusional disorder: The role of personality and emotions on delusional ideation.
   Compr Psychiatry. 2018;85:78-83.
   PubMed     Text format     Abstract available
   
   
8. DE MEDEIROS HLV, Vasconcelos SC, Elkis H, Martins DR, et al
   The Brief Negative Symptom Scale: Validation in a multicenter Brazilian study.
   Compr Psychiatry. 2018;85:42-47.
   PubMed     Text format     Abstract available
   
   

   
   J Abnorm Psychol

9. GUPTA T, Haase CM, Strauss GP, Cohen AS, et al
   Alterations in facial expressivity in youth at clinical high-risk for psychosis.
   J Abnorm Psychol. 2019 Mar 14. pii: 2019-13436-001. doi: 10.1037/abn0000413.
   PubMed     Text format     Abstract available
   
   

   
   J Nerv Ment Dis

10. WEHBE J, Haddad C, Obeid S, Hallit S, et al
    Prevalence of Obsessive-Compulsive Disorder in Patients With Schizophrenia and Outcome on Positive and Negative Symptoms, Cognition, and Quality of Life.
    J Nerv Ment Dis. 2019 Mar 6. doi: 10.1097/NMD.0000000000000956.
    PubMed     Text format     Abstract available
    
    

    
    Mol Psychiatry

11. DEMICHELE-SWEET MAA, Weamer EA, Klei L, Vrana DT, et al
    Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease.
    Mol Psychiatry. 2019 Mar 12. pii: 10.1038/s41380-019-0373.
    PubMed     Text format     Abstract available
    
    
12. ORLOVSKA-WAAST S, Kohler-Forsberg O, Brix SW, Nordentoft M, et al
    Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Mol Psychiatry. 2019 Mar 12. pii: 10.1038/s41380-019-0381.
    PubMed     Text format     Abstract available
    
    

    
    Neuropsychology

13. XIU M, Zhang G, Chen N, Chen S, et al
    The TNF-alpha gene -1031T>C polymorphism is associated with onset age but not with risk of schizophrenia in a Chinese population.
    Neuropsychology. 2019 Mar 11. pii: 2019-13343-001. doi: 10.1037/neu0000535.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

14. CRESPO Y, Ibanez A, Soriano MF, Iglesias S, et al
    Handwriting movements for assessment of motor symptoms in schizophrenia spectrum disorders and bipolar disorder.
    PLoS One. 2019;14:e0213657.
    PubMed     Text format     Abstract available
    
    

    
    Psychiatry Res

15. HILLMANN TE, Riehle M, Lincoln TM
    Reduced scanning of salient facial features mediates the association between paranoia and emotion recognition.
    Psychiatry Res. 2018;269:430-436.
    PubMed     Text format     Abstract available
    
    
16. BARRY EF, Vanes LD, Andrews DS, Patel K, et al
    Mapping cortical surface features in treatment resistant schizophrenia with in vivo structural MRI.
    Psychiatry Res. 2019;274:335-344.
    PubMed     Text format     Abstract available
    
    
17. OKRUSZEK L, Jarkiewicz M, Szrubarz P, Wichniak A, et al
    Many ways to forget - Neurophysiology of directed forgetting mechanisms in schizophrenia.
    Psychiatry Res. 2019;274:358-364.
    PubMed     Text format     Abstract available
    
    
18. ABDIN E, Chong SA, Seow E, Peh CX, et al
    A comparison of the reliability and validity of SF-6D, EQ-5D and HUI3 utility measures in patients with schizophrenia and patients with depression in Singapore.
    Psychiatry Res. 2019;274:400-408.
    PubMed     Text format     Abstract available
    
    
19. SONG J, Borlido C, De Luca V, Burton L, et al
    Patient versus rater evaluation of symptom severity in treatment resistant schizophrenia receiving clozapine.
    Psychiatry Res. 2019;274:409-413.
    PubMed     Text format     Abstract available
    
    
20. TEMESGEN WA, Chien WT, Bressington D
    Factors influencing subjective recovery of people with recent-onset psychosis: A cross-sectional study in a low-income sub-Saharan country.
    Psychiatry Res. 2019 Feb 27:12282. doi: 10.1016/j.psychres.2019.
    PubMed     Text format     Abstract available
    
    
21. KIM SJ, Hong YJ, Kim MW, Jung YH, et al
    Inflexible eye fixation pattern in schizophrenia affecting decision-making on daily life.
    Psychiatry Res. 2019;274:414-420.
    PubMed     Text format     Abstract available
    
    
22. TEMESGEN WA, Chien WT, Bressington D
    Factors influencing subjective recovery of people with recent-onset psychosis: A cross-sectional study in a low-income Sub-Saharan country.
    Psychiatry Res. 2019;274:421-429.
    PubMed     Text format     Abstract available
    
    
23. IKONEN H, Palaniswamy S, Nordstrom T, Jarvelin MR, et al
    Vitamin D status and correlates of low vitamin D in schizophrenia, other psychoses and non-psychotic depression - The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2019 Mar 12. pii: S0165-1781(18)32026.
    PubMed     Text format     Abstract available
    
    

    
    Psychol Med

24. HAINING K, Matrunola C, Mitchell L, Gajwani R, et al
    Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.
    Psychol Med. 2019 Mar 13:1-9. doi: 10.1017/S0033291718003975.
    PubMed     Text format     Abstract available
    
    
25. ISVORANU AM, Guloksuz S, Epskamp S, van Os J, et al
    Toward incorporating genetic risk scores into symptom networks of psychosis.
    Psychol Med. 2019 Mar 14:1-8. doi: 10.1017/S003329171900045.
    PubMed     Text format     Abstract available
    
    
26. STEEN NE, Dieset I, Hope S, Vedal TSJ, et al
    Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
    Psychol Med. 2019 Mar 14:1-12. doi: 10.1017/S0033291719000400.
    PubMed     Text format     Abstract available
    
    
27. GLAUSIER JR, Kelly MA, Salem S, Chen K, et al
    Proxy measures of premortem cognitive aptitude in postmortem subjects with schizophrenia.
    Psychol Med. 2019 Mar 14:1-8. doi: 10.1017/S0033291719000382.
    PubMed     Text format     Abstract available
    
    
28. RYDKJAER J, Jepsen JRM, Pagsberg AK, Fagerlund B, et al
    Do young adolescents with first-episode psychosis or ADHD show sensorimotor gating deficits?
    Psychol Med. 2019 Mar 15:1-9. doi: 10.1017/S0033291719000412.
    PubMed     Text format     Abstract available
    
    

    
    Schizophr Res

29. LAPPIN JM, Wijaya M, Watkins A, Morell R, et al
    Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
    Schizophr Res. 2018;199:367-373.
    PubMed     Text format     Abstract available
    
    
30. LI KJ, Gurrera RJ, Delisi LE
    Potentially fatal outcomes associated with clozapine.
    Schizophr Res. 2018;199:386-389.
    PubMed     Text format     Abstract available
    
    
31. KNOPH KN, Morgan RJ 3rd, Palmer BA, Schak KM, et al
    Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
    Schizophr Res. 2018;199:17-30.
    PubMed     Text format     Abstract available
    
    
32. ZHOU HY, Wong KK, Shi LJ, Cui XL, et al
    Suspiciousness in young minds: Convergent evidence from non-clinical, clinical and community twin samples.
    Schizophr Res. 2018;199:135-141.
    PubMed     Text format     Abstract available
    
    
33. ROSEN C, McCarthy-Jones S, Jones N, Chase KA, et al
    Negative voice-content as a full mediator of a relation between childhood adversity and distress ensuing from hearing voices.
    Schizophr Res. 2018;199:361-366.
    PubMed     Text format     Abstract available
    
    
34. LI J, Loebel A, Meltzer HY
    Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.
    Schizophr Res. 2018;199:203-213.
    PubMed     Text format     Abstract available
    
    
35. BIRNBAUM R, Weinberger DR
    A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia.
    Schizophr Res. 2019 Mar 5. pii: S0920-9964(19)30065.
    PubMed     Text format     Abstract available
    
    
36. STOCHL J, Whittier A, Wagner AP, Veijola J, et al
    Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966.
    Schizophr Res. 2019 Mar 6. pii: S0920-9964(19)30073.
    PubMed     Text format     Abstract available
    
    
37. OTA M, Sato N, Yoshida F, Hattori K, et al
    A polymorphism of the methylenetetrahydrofolate reductase gene confers susceptibility to schizophrenia and related brain changes.
    Schizophr Res. 2019 Mar 6. pii: S0920-9964(19)30084.
    PubMed     Text format    
    
    
38. MALASPINA D, Kranz T, Kleinhaus K, Daboul S, et al
    Short duration of marriage at conception as an independent risk factor for schizophrenia.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30083.
    PubMed     Text format     Abstract available
    
    
39. MAZZA E, Spangaro M, Poletti S, Cavallaro R, et al
    Genetic variability of glutamate reuptake: Effect on white matter integrity and working memory in schizophrenia.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30086.
    PubMed     Text format    
    
    
40. DAL MAS C, Nani JV, Noto C, Yonamine CM, et al
    Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30081.
    PubMed     Text format     Abstract available
    
    
41. KAO AC, Safarikova J, Marquardt T, Mullins B, et al
    Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study.
    Schizophr Res. 2019 Mar 12. pii: S0920-9964(19)30085.
    PubMed     Text format    
    
    
42. CABUNGCAL JH, Steullet P, Kraftsik R, Cuenod M, et al
    A developmental redox dysregulation leads to spatio-temporal deficit of parvalbumin neuron circuitry in a schizophrenia mouse model.
    Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30077.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: